01 2ENDO OPERATIONS
02 2MYLAN
03 3TAKEDA PHARMS USA
04 2TWI PHARMS
01 8CAPSULE, DELAYED RELEASE;ORAL
02 1TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL
01 1DISCN
02 8RX
01 2DEXILANT
02 1DEXILANT SOLUTAB
03 6DEXLANSOPRAZOLE
01 6No
02 3Yes
RLD : Yes
TE Code : AB
Brand Name : DEXILANT
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : 30MG
Approval Date : 2009-01-30
Application Number : 22287
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Brand Name : DEXILANT
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : 60MG
Approval Date : 2009-01-30
Application Number : 22287
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code :
Brand Name : DEXILANT SOLUTAB
Dosage Form : TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL
Dosage Strength : 30MG
Approval Date : 2016-01-26
Application Number : 208056
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code : AB
Brand Name : DEXLANSOPRAZOLE
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : 30MG
Approval Date : 2022-09-16
Application Number : 202666
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : DEXLANSOPRAZOLE
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : 60MG
Approval Date : 2022-09-16
Application Number : 202666
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : DEXLANSOPRAZOLE
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : 30MG
Approval Date : 2024-01-19
Application Number : 205205
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : DEXLANSOPRAZOLE
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : 60MG
Approval Date : 2024-01-19
Application Number : 205205
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Brand Name : DEXLANSOPRAZOLE
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : 60MG
Approval Date : 2017-04-19
Application Number : 202294
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Brand Name : DEXLANSOPRAZOLE
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : 30MG
Approval Date : 2022-06-16
Application Number : 202294
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?